glp 1 nutrition GLP-1 Support Stack: Save up to 20% Today with Our Bundle All about GLP-1! Whether you're

News provided by Ro Apr 09, 2026, 07:15 ET Foundayo gives patients a new once daily pill option and expands Ro's comprehensive weight loss formulary NEW YORK, April 9, 2026 /PRNewswire/ -- Ro, the leading direct-to-patient healthcare company, today announced eligible patients can now access Foundayo (orforglipron) Eli Lilly Company's newest oral GLP-1 innovation on the Ro platform, adding to Ro's already comprehensive formulary of FDA-approved GLP-1s

Participants who had been taking high dose Wegovy and switched to daily oral Foundayo regained an average of 0.9 kilograms (kg), or about 2 pounds (lbs) over 1 year

Different medications have different tolerance windows for room temperature exposure

For additional details on these findings and Omadas Enhanced GLP1 Care Track, please connect with your account manager or contact a member of our sales leadership team.

Coexisting conditions affecting the tumor risk of GLP-1RAs Metabolic diseases Large-scale clinical studies have confirmed that the use of GLP-1RAs in diabetic populations does not increase the cancer risk occurrence